Integral Derivatives’s Mead Johnson Nutrition Company MJN Stock Holding History

Integral Derivatives’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-44,200	Closed	-$3.94M	–	1385
2017 Q1	$3.94M	Buy	44,200 +11,200	+34%	+$921K	0.07%	173
2016 Q4	$2.33M	Buy	33,000 +25,900	+365%	+$1.93M	0.04%	285
2016 Q3	$561K	Sell	7,100 -1,600	-18%	-$136K	0.01%	595
2016 Q2	$790K	Buy	+8,700	New	+$737K	0.02%	475
2016 Q1	–	Sell	-5,000	Closed	-$395K	–	1233
2015 Q4	$395K	Buy	+5,000	New	+$394K	0.01%	712
2015 Q1	–	Sell	-15,000	Closed	-$1.51M	–	1536
2014 Q4	$1.51M	Buy	+15,000	New	+$1.5M	0.03%	531
2014 Q3	–	Sell	-5,500	Closed	-$512K	–	1633
2014 Q2	$512K	Sell	5,500 -27,500	-83%	-$2.4M	0.01%	924
2014 Q1	$2.74M	Buy	33,000 +29,500	+843%	+$2.39M	0.05%	321
2013 Q4	$293K	Buy	+3,500	New	+$285K	﹤0.01%	1224

Other funds holding MJN

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FNBOO

First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Integral Derivatives's MJN Position: Q2 2017 in Review

Integral Derivatives sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 23,864 shares — an estimated $2.13M sold.

Integral Derivatives first reported a position in MJN in Q1 2014 and held it in 7 quarters. The position peaked at $2.13M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

Integral Derivatives reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
Integral Derivatives sold 23,864 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $2.13M.
Integral Derivatives first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 7 quarters.
Integral Derivatives's Mead Johnson Nutrition Company position peaked at $2.13M in Q1 2017.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.